Ra Capital Management, L.P. Fulcrum Therapeutics, Inc. Transaction History
Ra Capital Management, L.P.
- $5.82 Billion
- Q3 2025
A detailed history of Ra Capital Management, L.P. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 10,229,099 shares of FULC stock, worth $88.7 Million. This represents 1.53% of its overall portfolio holdings.
Number of Shares
10,229,099
Previous 10,229,099
-0.0%
Holding current value
$88.7 Million
Previous $70.4 Million
26.74%
% of portfolio
1.53%
Previous 1.54%
Shares
6 transactions
Others Institutions Holding FULC
# of Institutions
133Shares Held
55.4MCall Options Held
176KPut Options Held
13.5K-
Suvretta Capital Management, LLC New York, NY5.38MShares$46.7 Million1.41% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$45.5 Million5.13% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$41.6 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.67MShares$40.5 Million1.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA3MShares$26 Million0.0% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $451M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...